696 related articles for article (PubMed ID: 18455982)
1. Tenets of PTEN tumor suppression.
Salmena L; Carracedo A; Pandolfi PP
Cell; 2008 May; 133(3):403-14. PubMed ID: 18455982
[TBL] [Abstract][Full Text] [Related]
2. PTEN mutation: many birds with one stone in tumorigenesis.
Liu W; Zhou Y; Reske SN; Shen C
Anticancer Res; 2008; 28(6A):3613-9. PubMed ID: 19189642
[TBL] [Abstract][Full Text] [Related]
3. SnapShot: PTEN signaling pathways.
Carracedo A; Salmena L; Pandolfi PP
Cell; 2008 May; 133(3):550.e1. PubMed ID: 18455993
[No Abstract] [Full Text] [Related]
4. The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer.
Assinder SJ; Dong Q; Kovacevic Z; Richardson DR
Biochem J; 2009 Jan; 417(2):411-21. PubMed ID: 19099539
[TBL] [Abstract][Full Text] [Related]
5. Assessment of PTEN tumor suppressor activity in nonmammalian models: the year of the yeast.
Cid VJ; Rodríguez-Escudero I; Andrés-Pons A; Romá-Mateo C; Gil A; den Hertog J; Molina M; Pulido R
Oncogene; 2008 Sep; 27(41):5431-42. PubMed ID: 18794878
[TBL] [Abstract][Full Text] [Related]
6. The PTEN-PI3K pathway: of feedbacks and cross-talks.
Carracedo A; Pandolfi PP
Oncogene; 2008 Sep; 27(41):5527-41. PubMed ID: 18794886
[TBL] [Abstract][Full Text] [Related]
7. Post-translational regulation of PTEN.
Wang X; Jiang X
Oncogene; 2008 Sep; 27(41):5454-63. PubMed ID: 18794880
[TBL] [Abstract][Full Text] [Related]
8. PTEN in brain tumors.
Haas-Kogan D; Stokoe D
Expert Rev Neurother; 2008 Apr; 8(4):599-610. PubMed ID: 18416662
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in the PI3K pathway in prostate cancer.
Sun X; Huang J; Homma T; Kita D; Klocker H; Schafer G; Boyle P; Ohgaki H
Anticancer Res; 2009 May; 29(5):1739-43. PubMed ID: 19443396
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of PTEN loss in cancer: It's all about diversity.
Álvarez-Garcia V; Tawil Y; Wise HM; Leslie NR
Semin Cancer Biol; 2019 Dec; 59():66-79. PubMed ID: 30738865
[TBL] [Abstract][Full Text] [Related]
11. PTEN, Insulin Resistance and Cancer.
Li A; Qiu M; Zhou H; Wang T; Guo W
Curr Pharm Des; 2017; 23(25):3667-3676. PubMed ID: 28677502
[TBL] [Abstract][Full Text] [Related]
12. The nuclear affairs of PTEN.
Planchon SM; Waite KA; Eng C
J Cell Sci; 2008 Feb; 121(Pt 3):249-53. PubMed ID: 18216329
[TBL] [Abstract][Full Text] [Related]
13. The functions and regulation of the PTEN tumour suppressor: new modes and prospects.
Lee YR; Chen M; Pandolfi PP
Nat Rev Mol Cell Biol; 2018 Sep; 19(9):547-562. PubMed ID: 29858604
[TBL] [Abstract][Full Text] [Related]
14. PTEN level in tumor suppression: how much is too little?
Carracedo A; Alimonti A; Pandolfi PP
Cancer Res; 2011 Feb; 71(3):629-33. PubMed ID: 21266353
[TBL] [Abstract][Full Text] [Related]
15. The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy.
Malaney P; Uversky VN; Davé V
Mol Biosyst; 2013 Nov; 9(11):2877-88. PubMed ID: 24056727
[TBL] [Abstract][Full Text] [Related]
16. In Cell and In Vitro Assays to Measure PTEN Ubiquitination.
Gupta A; Maccario H; Kriplani N; Leslie NR
Methods Mol Biol; 2016; 1388():155-65. PubMed ID: 27033076
[TBL] [Abstract][Full Text] [Related]
17. PTEN: History of a Tumor Suppressor.
Salmena L
Methods Mol Biol; 2016; 1388():3-11. PubMed ID: 27033066
[TBL] [Abstract][Full Text] [Related]
18. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
Christine A; Park MK; Song SJ; Song MS
Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
[TBL] [Abstract][Full Text] [Related]
19. PTEN enters the nuclear age.
Baker SJ
Cell; 2007 Jan; 128(1):25-8. PubMed ID: 17218252
[TBL] [Abstract][Full Text] [Related]
20. PTEN function in normal and neoplastic growth.
Chow LM; Baker SJ
Cancer Lett; 2006 Sep; 241(2):184-96. PubMed ID: 16412571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
